Get startedLog in
    Picture of Theratechnologies logo

    THTX — Theratechnologies Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

    2020
    November 30th
    2021
    November 30th
    2022
    November 30th
    2023
    November 30th
    2024
    November 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-22.7-31.7-47.2-24-8.31
    Depreciation
    Amortisation
    Non-Cash Items6.878.2611.315.220
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-6.270.2428.73-0.241-12.1
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-13.6-14.5-14.7-5.682.38
    Capital Expenditures-0.032-0.166-0.985-1.82-1.5
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items4.81-12.39.672.932.44
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities4.78-12.58.681.110.942
    Financing Cash Flow Items-3.31-7.15-3.97-2.48-5.4
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-7.2334.69.6614.8-21.5
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-15.97.663.4610.2-18.2